About This Page
This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.
Key points
- Do not delay treatment for diagnostic purity: symptomatic or unsafe patients need oral glucose, IV dextrose, or glucagon immediately
- Whipple triad supports true hypoglycemia: compatible symptoms, low measured plasma glucose, and symptom resolution when glucose is corrected
- Most adult hypoglycemia is medication-related: insulin, sulfonylureas, missed meals, renal impairment, alcohol, or dosing error
- Recurrent or unexplained hypoglycemia requires a critical sample during the episode
- Sulfonylurea hypoglycemia can recur after dextrose; prolonged observation and octreotide may be required
Approach to the Presentation
Hypoglycemia presents with tremor, sweating, hunger, palpitations, anxiety, confusion, behavioural change, visual disturbance, seizure, coma, or falls. The immediate MCCQE1 priority is safety: measure bedside glucose, treat promptly, reassess neurological status, and prevent recurrence. Once the patient is safe, determine whether this is diabetes-treatment related, fasting illness-related, alcohol-related, adrenal or pituitary disease, hepatic or renal failure, post-bariatric/reactive hypoglycemia, insulinoma, or factitious exposure. In patients using insulin or insulin secretagogues, prevention requires review of timing, food access, renal function, driving, exercise, alcohol, and hypoglycemia awareness.
Differential Diagnosis
| diagnosis | likelihood | key features | distinguishing test |
|---|---|---|---|
| Insulin-induced Hypoglycemia | must-not-miss | Diabetes on insulin, dosing error, missed meal, increased exercise, renal impairment, weight loss, injection mix-up, or pump problem | Low glucose with high insulin and low C-peptide if exogenous insulin; medication history often diagnostic |
| Sulfonylurea or Meglitinide Hypoglycemia | must-not-miss | Older adult, renal impairment, glyburide or gliclazide exposure, accidental ingestion, recurrent/prolonged hypoglycemia after dextrose | Sulfonylurea screen; high insulin and high C-peptide during hypoglycemia |
| Sepsis or Critical Illness Hypoglycemia | must-not-miss | Fever or hypothermia, hypotension, confusion, frailty, liver disease, poor intake | Sepsis workup, lactate, cultures, CBC, renal/liver function |
| Adrenal Crisis / Cortisol Deficiency | must-not-miss | Weakness, abdominal pain, vomiting, hypotension, hyponatremia, hyperkalemia, weight loss, hyperpigmentation or recent steroid withdrawal | Cortisol/ACTH if stable; do not delay hydrocortisone if crisis suspected |
| Alcohol-related Hypoglycemia | common | Alcohol binge or chronic alcohol use, poor glycogen stores, fasting, malnutrition, overnight presentation | History, ethanol level if needed, ketones, liver tests; low insulin state |
| Renal or Hepatic Failure | common | Reduced insulin clearance in kidney disease; impaired gluconeogenesis in liver failure; malnutrition and polypharmacy | Creatinine/eGFR, liver enzymes, INR, albumin, medication review |
| Reactive or Post-bariatric Hypoglycemia | less common | Symptoms 1-3 hours after meals, especially after Roux-en-Y gastric bypass; adrenergic symptoms predominate | Documented low plasma glucose during symptoms; mixed-meal testing in specialist care |
| Insulinoma | rare | Recurrent fasting hypoglycemia, weight gain from frequent eating, morning confusion, exercise-related episodes, no diabetes medications | Supervised 72-hour fast with inappropriately high insulin, C-peptide, and proinsulin |
| Factitious Hypoglycemia | rare | Access to insulin or secretagogues, health care exposure, discordant history, recurrent unexplained episodes | Exogenous insulin = high insulin/low C-peptide; sulfonylurea = high insulin/high C-peptide with positive screen |
Red Flags & Key History
Symptoms
Seizure, coma, focal neurological signs, or inability to swallow safely
Recurrent hypoglycemia after correction — suggests long-acting insulin, sulfonylurea, renal failure, sepsis, or poor glycogen reserve
Hypotension, vomiting, abdominal pain, or steroid withdrawal — consider adrenal crisis
Hypoglycemia while driving, operating machinery, or caring for dependants — immediate safety counselling required
No diabetes medication history but repeated fasting episodes — consider insulinoma or factitious exposure
Tremor, palpitations, sweating, hunger, and anxiety — adrenergic symptoms
Confusion, irritability, behaviour change, blurred vision, weakness, and headache — neuroglycopenic symptoms
Signs
Reduced Glasgow Coma Scale or unsafe airway
Hypothermia, hypotension, or signs of sepsis
Malnutrition, jaundice, ascites, or chronic kidney disease signs
Hyperpigmentation, postural hypotension, or salt craving suggesting adrenal insufficiency
Injection sites, insulin pump, or medication blister packs may provide key diagnostic clues
Approach to Investigation
First-line
Capillary glucose followed by laboratory plasma glucoseTreat immediately if low or if high clinical suspicion with unsafe patient. Confirm with lab glucose when possible
Medication and timing reviewInsulin type/dose, sulfonylureas, renal function, alcohol, meal timing, exercise, and recent weight loss
Electrolytes, creatinine/eGFR, liver tests, CBC, and infection screenIdentify renal impairment, hepatic failure, sepsis, malnutrition, or concurrent illness
ECG and troponin if older patient or cardiac symptomsHypoglycemia can precipitate ischemia or arrhythmia
Second-line
Critical sample during hypoglycemiaSend plasma glucose, insulin, C-peptide, proinsulin, beta-hydroxybutyrate, sulfonylurea/meglitinide screen, cortisol, and sometimes growth hormone
Morning cortisol or ACTH stimulation testingFor suspected adrenal insufficiency once stable; in crisis draw cortisol/ACTH if feasible and give hydrocortisone
A1c and glucose pattern reviewAssesses overtreatment, glycemic targets, nocturnal lows, frailty goals, and need for de-intensification
Specialist
Supervised fast or mixed-meal testEndocrinology-directed tests for suspected insulinoma or post-prandial hypoglycemia
Pancreatic imagingOnly after biochemical confirmation of endogenous hyperinsulinemic hypoglycemia
Management Principles
Diabetes Canada Clinical Practice Guidelines: Hypoglycemia1
Immediate treatment
- If awake and able to swallow: give fast-acting carbohydrate, recheck glucose after 15 minutes, and repeat if still low
- If decreased consciousness, seizure, or unsafe swallow: give IV dextrose; if no IV access, give glucagon and arrange urgent medical care
- After recovery, give longer-acting carbohydrate or a meal if next meal is not imminent
2
Prevent recurrence
- Observe longer for sulfonylurea, long-acting insulin, renal failure, intentional overdose, alcohol-related hypoglycemia, or critical illness
- Use octreotide for recurrent sulfonylurea-induced hypoglycemia with toxicology or specialist guidance
- Adjust insulin/secretagogue dose, meal timing, exercise plan, alcohol advice, and monitoring before discharge
3
Safety and education
- Review recognition, treatment, carrying glucose, sick-day rules, and when to seek urgent help
- Discuss driving and occupational risk after severe hypoglycemia or impaired awareness according to local provincial requirements
- Prescribe glucagon for patients at risk of severe hypoglycemia and teach family/supports how to use it
Complications & Pitfalls
- Failure to treat first: Severe hypoglycemia is immediately reversible; diagnostic workup must not delay dextrose or glucagon
- Rebound hypoglycemia: Dextrose alone may not prevent recurrence after sulfonylureas or long-acting insulin
- Missing renal impairment: Declining eGFR substantially increases insulin and sulfonylurea exposure
- Over-tight targets in frailty: Recurrent hypoglycemia should trigger de-intensification rather than simply more monitoring
- No critical sample: Unexplained episodes need insulin, C-peptide, and sulfonylurea screen during hypoglycemia
MCCQE1 Exam Tips
- 1For a confused or seizing patient, bedside glucose is a vital sign. Treat immediately if low
- 2Diabetes Canada teaching uses fast-acting carbohydrate followed by recheck and repeat if still low
- 3High insulin + low C-peptide = exogenous insulin. High insulin + high C-peptide = endogenous insulin or sulfonylurea
- 4Sulfonylurea hypoglycemia in an older patient with kidney disease is a medication-safety favourite
- 5Adrenal crisis can present with hypoglycemia, hypotension, hyponatremia, hyperkalemia, abdominal pain, and shock
- 6CanMEDS health advocate angle: de-intensify unsafe therapy in frail older adults rather than chasing low A1c targets
Put your reading into practice
Topic-specific question practice is not linked for this article yet.
Choose MCCQE Part I questions from the existing bank. General exam practice covers your selected topics; it is not filtered to this article. Your usual question-bank access applies.
Choose MCCQE Part I practiceAfter your session, return to this section to revisit the reading and choose your next review.
Verified Sources & References
related resources
Save your place and choose what comes next
Endocrine & Metabolic · Article 29 of 44